Biotech Innovations: The Future of Ready-to-Use Cancer Treatments
The Rice Business Healthcare Association Healthcare Leadership Series presents Biotech Innovations: The Future of Ready-to-Use Cancer Treatments featuring Dr. May Daher, Associate Professor of Medicine in the Department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center.
Rice Alumni and Students | General Admission and Rice Faculty/Staff
As biotechnology reshapes the future of oncology, healthcare leaders must understand how innovations move from research to scalable treatment models. In this session, Dr. Daher will discuss the development of ready-to-use (“off-the-shelf”) cellular therapies, including engineered natural killer (NK) cells, and what these advances mean for the future of cancer care, clinical translation, and the evolving biotech ecosystem.
The discussion will highlight how breakthrough therapies move from the lab to real-world impact and what these developments mean for healthcare leaders, innovators, and the future of cancer treatment.
This session is open to current students and alumni; complimentary for non-faculty /staff and non-alumni guests. Rice Business students and alumni, please use your NETID or student/alumni login.
Rice Business alumni, please email cdo@rice.edu if you are having issues with your 12twenty login.
